Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study
- PMID: 35733230
- PMCID: PMC9215019
- DOI: 10.1186/s13756-022-01103-0
Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study
Abstract
Background: Carbapenem-resistant gram-negative bacteria (CRGNB) have become a public health concern worldwide. The risk factors associated with CRGNB infection after colonization are unknown, nor is the optimal timing of antibiotic treatment, warranting further investigation.
Methods: A 4-year single-center prospective observational study was conducted. CRGNB-colonized patients were incorporated on admission into our observation cohort for an active surveillance culture program, and analysis of risk factors associated with infections after CRGNB colonization was performed. We divided patients into empirical antibiotic therapy groups and standard antibiotic therapy groups according to whether antibiotics were used before or after cultures yielded a result to explore the relationship between the timing of antibiotics and clinical efficacy.
Results: 152 out of 451 CRGNB-colonized patients in the prospective observational cohort developed CRGNB infection. The risk factors associated with CRGNB infection after colonization included CRKP (P < 0.001, OR = 3.27) and CRPA (P < 0.001, OR = 2.97) colonization, history of carbapenems use (P < 0.001, OR = 5.48), and immunocompromise (P < 0.001, OR = 7.07). There were 88 infected patients in the empirical antibiotic therapy groups and 64 in standard antibiotic therapy groups. The mortality was lower in empirical therapy groups than standard therapy groups (17.0% vs. 37.5%, P = 0.004, OR = 0.32).
Conclusions: CRGNB colonized patients who are prone to infection have some high-risk factors included CRKP and CRPA colonization, immunocompromise, and prior carbapenems use. Once infection occurs in CRGNB-colonized patients, early use of effective antibiotics may be associated with reduced mortality, but more studies are needed.
Keywords: Active surveillance; Carbapenem-resistant gram-negative bacteria; Empirical antibiotic therapy; Infection after colonization; Nosocomial infection prevention and control.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
A Longitudinal Study of Spontaneous Gut Decolonization of Carbapenem-resistant Gram-negative Bacteria in Neonatal and Pediatric Patients.Pediatr Infect Dis J. 2022 Aug 1;41(8):648-653. doi: 10.1097/INF.0000000000003562. Epub 2022 Jul 13. Pediatr Infect Dis J. 2022. PMID: 35446811
-
Effects of an Active Surveillance Program and Enhanced Infection Control Measures on Carbapenem-Resistant Gram-Negative Bacterial Carriage and Infections in Pediatric Intensive Care.Microb Drug Resist. 2019 Nov;25(9):1347-1356. doi: 10.1089/mdr.2019.0061. Epub 2019 Jul 31. Microb Drug Resist. 2019. PMID: 31364923
-
Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care.J Hosp Infect. 2018 Aug;99(4):396-404. doi: 10.1016/j.jhin.2018.05.010. Epub 2018 May 21. J Hosp Infect. 2018. PMID: 29792971
-
A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria.Rev Esp Quimioter. 2022 Oct;35(5):455-467. doi: 10.37201/req/062.2022. Epub 2022 Jul 21. Rev Esp Quimioter. 2022. PMID: 35859521 Free PMC article.
-
Efficiency of combination therapy versus monotherapy for the treatment of infections due to carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis.Syst Rev. 2024 Dec 19;13(1):309. doi: 10.1186/s13643-024-02695-x. Syst Rev. 2024. PMID: 39702227 Free PMC article.
Cited by
-
Early appropriate therapy with polymyxin B reduces the mortality in burn sepsis caused by carbapenem-resistant gram-negative bacteria: a retrospective analysis.Eur J Clin Microbiol Infect Dis. 2025 Jun;44(6):1433-1442. doi: 10.1007/s10096-025-05119-3. Epub 2025 Apr 3. Eur J Clin Microbiol Infect Dis. 2025. PMID: 40178717
-
Active Screening of Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae for Subsequent Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplantation.Infect Drug Resist. 2022 Oct 18;15:5993-6006. doi: 10.2147/IDR.S387615. eCollection 2022. Infect Drug Resist. 2022. PMID: 36262593 Free PMC article.
-
Risk factors and mortality rates of carbapenem-resistant Gram-negative bacterial infections in intensive care units.J Intensive Med. 2024 Jan 9;4(3):347-354. doi: 10.1016/j.jointm.2023.11.007. eCollection 2024 Jul. J Intensive Med. 2024. PMID: 39035617 Free PMC article.
-
Correlation between Stenotrophomonas maltophilia incidence and systemic antibiotic use: A 10-year retrospective, observational study in Hungary.Eur J Microbiol Immunol (Bp). 2024 Mar 5;14(2):185-194. doi: 10.1556/1886.2024.00022. Print 2024 May 14. Eur J Microbiol Immunol (Bp). 2024. PMID: 38441614 Free PMC article.
-
Mortality rate and factors associated with mortality of carbapenem-resistant Enterobacteriaceae infection.Drug Target Insights. 2023 Oct 27;17:120-125. doi: 10.33393/dti.2023.2622. eCollection 2023 Jan-Dec. Drug Target Insights. 2023. PMID: 38028024 Free PMC article.
References
-
- Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Diseases Society of America guidance on the treatment of extended-spectrum beta-lactamase producing enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa) Clin Infect Dis. 2021;72(7):1109–1116. doi: 10.1093/cid/ciab295. - DOI - PubMed
-
- Karampatakis T, Tsergouli K, Iosifidis E, Antachopoulos C, Karapanagiotou A, Karyoti A, et al. Impact of active surveillance and infection control measures on carbapenem-resistant gram-negative bacterial colonization and infections in intensive care. J Hosp Infect. 2018;99(4):396–404. doi: 10.1016/j.jhin.2018.05.010. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources